Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean 3594 4s 5?
Displaying drugs 6151 - 6175 of 10607 in total

LGH-447

LGH-447 is under investigation in clinical trial NCT02160951 (Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies).
Investigational
Matched Iupac: … N-{4-[(1R,3S,5S)-3-amino-5-methylcyclohexyl]pyridin-3-yl}-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide …

GsMtx-4

GsMtx-4 is a peptide found in tarantula venom that inhibits mechanosensitive ion channel (MSC) activity.
Investigational
Matched Name: … GsMtx-4 …
Matched Description: … GsMtx-4 is a peptide found in tarantula venom that inhibits mechanosensitive ion channel (MSC) activity …

BRM-421

Investigational

MG-4101

Investigational

Tocladesine

Tocladesine has been used in trials studying the treatment of Colorectal Cancer and Multiple Myeloma and Plasma Cell Neoplasm.
Investigational

SO-101

SO-101(Silenor) is a low-dose oral tablet formulation of doxepin hydrochloride that is patent protected for its use in insomnia. Doxepin has been prescribed for more than 40 years for the treatment of depression and anxiety at dosages typically ranging from 75 mg to 300 mg per day.
Investigational

S-3304

S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others.
Investigational
Matched Name: … S-3304 …
Matched Iupac: … (2R)-3-(1H-indol-3-yl)-2-{5-[2-(4-methylphenyl)ethynyl]thiophene-2-sulfonamido}propanoic acid …
Matched Description: … S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung …

ST-101

ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. ST101 has been used in trials studying the treatment of Essential Tremor and Alzheimer's Disease.
Investigational

S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea

Experimental
Matched Name: … S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea …
Matched Iupac: … (E)-N'-[4-(trifluoromethyl)phenyl](ethylsulfanyl)methanimidamide …

N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide

Experimental
Matched Name: … N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide …
Matched Iupac: … 2-{[1,1'-biphenyl]-4-sulfonamido}-N-oxoacetamide …

N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide

Experimental
Matched Name: … N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide …
Matched Iupac: … (2S)-N-(4-cyano-1-methylpiperidin-4-yl)-3-cyclohexyl-2-[(morpholine-4-carbonyl)amino]propanamide …

Lorigerlimab

Lorigerlimab is under investigation in clinical trial NCT05848011 (A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-resistant Prostate Cancer).
Investigational
Matched Synonyms: … DEATH 1, PD1, PD-1, CD279)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, …

XR5944

XR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.
Investigational

2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide

Experimental
Matched Name: … 2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide …
Matched Iupac: … 2-(4-fluorobenzenesulfonamido)-N-oxoacetamide …

Xylose-derived lactam oxime

Experimental
Matched Iupac: … (2Z,3S,4S,5R)-2-(hydroxyimino)piperidine-3,4,5-triol …

Arginineamide

Experimental
Matched Iupac: … [amino({[(4S)-4-amino-4-carbamoylbutyl]amino})methylidene]azanium …

4-Deoxy-Alpha-D-Glucose

Experimental
Matched Name: … 4-Deoxy-Alpha-D-Glucose …
Matched Iupac: … (2S,3R,4S,6S)-6-(hydroxymethyl)oxane-2,3,4-triol …

3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid

Experimental
Matched Name: … 3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid …
Matched Iupac: … (3R,4S)-3-(2-aminoethyl)-4-(aminomethyl)heptanedioic acid …

alpha-D-quinovopyranose

The pyranose form of D-quinovose with an α-configuration at the anomeric position .
Experimental
Matched Iupac: … (2S,3R,4S,5S,6R)-6-methyloxane-2,3,4,5-tetrol …

Atagabalin

Atagabalin has been used in trials studying the treatment of Insomnia, Primary Insomnia, and Nonrestorative Sleep.
Investigational
Matched Iupac: … 2-[(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid …

Dasotraline

Dasotraline is a serotonin, norepinephrine and dopamine reuptake inhibitor (SNDRI) that is under investigation for the treatment of Binge Eating Disorder, Adult Attention Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder, and Adult Attention Deficit Hyperactivity Disorder.
Investigational
Matched Iupac: … (1R,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine …

Desmethylsertraline

Desmethylsertraline is a metabolite of sertraline.
Experimental
Matched Iupac: … (1S,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine …

(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID

Experimental
Matched Iupac: … 7-{3-hydroxy-5-oxo-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl}hept-5-enoic acid …

4-PIPERIDIN-4-YLBUTANAL

Experimental
Matched Name: … 4-PIPERIDIN-4-YLBUTANAL …
Matched Iupac: … 4-(piperidin-4-yl)butanal …

4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose

Experimental
Matched Name: … 4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl …
Matched Iupac: … (2S,3R,4R,5S,6R)-5-{[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl …
Displaying drugs 6151 - 6175 of 10607 in total